CASI Pharmaceuticals
Social media
CASI Pharmaceuticals Logo
About CASI Pharmaceuticals
CASI Pharmaceuticals Holdings Inc is a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, with operations in China, the United States, and internationally. The company offers EVOMELA, an intravenous formulation of melphalan for stem cell transplantation and multiple myeloma, and is advancing a pipeline of hematology, oncology, and autoimmune disease treatments, including monoclonal antibodies and CAR-T therapies. CASI conducts commercial, clinical, and R&D activities through subsidiaries in China and its head office in Rockville, Maryland.
Address
1701-1702, China Central Office Tower 1, No. 81 Jianguo Road Chaoyang District
Beijing, 100025
China
Year founded
1970
Number of employees
200-300
Sector
Health Care
Industry Group
Pharmaceuticals, Biotechnology & Life Sciences
Industry
Biotechnology
Report inaccurate data
Request an update to help us keep the brand up-to-date.
